154 related articles for article (PubMed ID: 29390045)
1. Upstream analysis of alternative splicing: a review of computational approaches to predict context-dependent splicing factors.
Carazo F; Romero JP; Rubio A
Brief Bioinform; 2019 Jul; 20(4):1358-1375. PubMed ID: 29390045
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics detection of modulators controlling splicing factor-dependent intron retention in the human brain.
Chen SX; Simpson E; Reiter JL; Liu Y
Hum Mutat; 2022 Nov; 43(11):1629-1641. PubMed ID: 35391504
[TBL] [Abstract][Full Text] [Related]
3. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.
Li D; Yu W; Lai M
Drug Discov Today; 2023 Sep; 28(9):103691. PubMed ID: 37385370
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.
Denichenko P; Mogilevsky M; Cléry A; Welte T; Biran J; Shimshon O; Barnabas GD; Danan-Gotthold M; Kumar S; Yavin E; Levanon EY; Allain FH; Geiger T; Levkowitz G; Karni R
Nat Commun; 2019 Apr; 10(1):1590. PubMed ID: 30962446
[TBL] [Abstract][Full Text] [Related]
5. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
[TBL] [Abstract][Full Text] [Related]
6. A bioinformatic analysis identifies circadian expression of splicing factors and time-dependent alternative splicing events in the HD-MY-Z cell line.
Genov N; Basti A; Abreu M; Astaburuaga R; Relógio A
Sci Rep; 2019 Jul; 9(1):11062. PubMed ID: 31363108
[TBL] [Abstract][Full Text] [Related]
7. Integration of CLIP experiments of RNA-binding proteins: a novel approach to predict context-dependent splicing factors from transcriptomic data.
Carazo F; Gimeno M; Ferrer-Bonsoms JA; Rubio A
BMC Genomics; 2019 Jun; 20(1):521. PubMed ID: 31238884
[TBL] [Abstract][Full Text] [Related]
8. Splicing factors: Insights into their regulatory network in alternative splicing in cancer.
Du JX; Zhu GQ; Cai JL; Wang B; Luo YH; Chen C; Cai CZ; Zhang SJ; Zhou J; Fan J; Zhu W; Dai Z
Cancer Lett; 2021 Mar; 501():83-104. PubMed ID: 33309781
[TBL] [Abstract][Full Text] [Related]
9. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.
Alvelos MI; Brüggemann M; Sutandy FR; Juan-Mateu J; Colli ML; Busch A; Lopes M; Castela Â; Aartsma-Rus A; König J; Zarnack K; Eizirik DL
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376132
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
[TBL] [Abstract][Full Text] [Related]
12. Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.
Jiménez M; Urtasun R; Elizalde M; Azkona M; Latasa MU; Uriarte I; Arechederra M; Alignani D; Bárcena-Varela M; Álvarez-Sola G; Colyn L; Santamaría E; Sangro B; Rodriguez-Ortigosa C; Fernández-Barrena MG; Ávila MA; Berasain C
Nucleic Acids Res; 2019 Apr; 47(7):3450-3466. PubMed ID: 30657957
[TBL] [Abstract][Full Text] [Related]
13. Dynamics and functional roles of splicing factor autoregulation.
Ding F; Su CJ; Edmonds KK; Liang G; Elowitz MB
Cell Rep; 2022 Jun; 39(12):110985. PubMed ID: 35732114
[TBL] [Abstract][Full Text] [Related]
14. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
Chang HL; Lin JC
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
[TBL] [Abstract][Full Text] [Related]
15. RNA Sequence Context Effects Measured In Vitro Predict In Vivo Protein Binding and Regulation.
Taliaferro JM; Lambert NJ; Sudmant PH; Dominguez D; Merkin JJ; Alexis MS; Bazile C; Burge CB
Mol Cell; 2016 Oct; 64(2):294-306. PubMed ID: 27720642
[TBL] [Abstract][Full Text] [Related]
16. Read-Split-Run: an improved bioinformatics pipeline for identification of genome-wide non-canonical spliced regions using RNA-Seq data.
Bai Y; Kinne J; Donham B; Jiang F; Ding L; Hassler JR; Kaufman RJ
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):503. PubMed ID: 27556805
[TBL] [Abstract][Full Text] [Related]
17. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Pellagatti A; Boultwood J
Adv Biol Regul; 2017 Jan; 63():59-70. PubMed ID: 27639445
[TBL] [Abstract][Full Text] [Related]
18. Splicing Activation by Rbfox Requires Self-Aggregation through Its Tyrosine-Rich Domain.
Ying Y; Wang XJ; Vuong CK; Lin CH; Damianov A; Black DL
Cell; 2017 Jul; 170(2):312-323.e10. PubMed ID: 28708999
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
20. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
